Clinical Trials Logo

Filter by:
NCT ID: NCT00208286 Terminated - Clinical trials for Osteoarthritis, Knee

P.F.C. Sigma Fixed Versus P.F.C. RP Mobile Bearing Total Knee Systems

Start date: November 2001
Phase: Phase 4
Study type: Interventional

This post-market clinical follow-up study was designed to compile long-term knee replacement outcomes of the PFC Sigma fixed and PFC Sigma mobile Rotating Platform (RP) knee systems. The first patient had surgery on November 8, 2001 and the final patient had surgery on July 29, 2005. There were 120 knees consented by a single site, which was the planned sample size in the study protocol, with 117 receiving one of the study devices. The study was terminated as the primary outcome was met and the investigator decided to conduct the study without sponsor support after 2009.

NCT ID: NCT00206700 Terminated - Crohn Disease Clinical Trials

Open-label Trial of Leukine in Active Crohn's Disease

Start date: February 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to establish a safety profile sargramostim administered in 8 week cycles to adult patients with active Crohn's disease.

NCT ID: NCT00206063 Terminated - Clinical trials for Stroke Prevention in Patients With Atrial Fibrillation

Long Term Open Follow-up With H376/95 vs. Warfarin

Start date: August 1999
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate tolerability of long-term treatment with ximelagatran compared to standard treatment with warfarin.

NCT ID: NCT00205998 Terminated - Clinical trials for Distal Radius Fractures

Surgical Plate Osteosynthesis of Distal Radius Fractures

Start date: December 2001
Phase: Phase 4
Study type: Interventional

Primary objective of the study is to demonstrate specific indications for the surgical treatment of distal radius fractures using the locking compression plate.

NCT ID: NCT00184548 Terminated - Trauma Clinical Trials

Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding

CONTROL
Start date: October 2005
Phase: Phase 3
Study type: Interventional

This trial is conducted globally. The purpose of the trial is to evaluate that activated recombinant human factor VII (eptacog alfa (activated)) is safe and effective in severely injured trauma patients by assessing mortality and morbidity. Please note that this trial and trial F7TRAUMA-1648 (NCT00323570) have been merged.

NCT ID: NCT00180843 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease

Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease

Start date: September 2005
Phase: N/A
Study type: Interventional

Subjects undergo history, examination, lung function assessment after informed consent has been obtained. All subjects will undergo ventilation-perfusion scans. If there first scan is normal they will undergo a second and final scan four weeks later. If abnormal they will undergo two further scans with either nebulized bronchodilator or nebulized saline prior to their second and third scans. Each time they will have repeat lung function tests prior to scanning. We will examine the regional changes in ventilation and perfusion and there relationship to lung function.

NCT ID: NCT00180830 Terminated - Cancer Clinical Trials

Glivec Phase II Pediatric Study

Start date: December 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Glivec is effective, in children, adolescents and young adults, in the treatment of malignant disease in which evidence suggests a potential pathogenic role of one or more of the tyrosine kinases known to be inhibited by Glivec.

NCT ID: NCT00165880 Terminated - Clinical trials for Metastatic Breast Cancer

An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine

Start date: December 2004
Phase: Phase 2
Study type: Interventional

The overall purpose of this study is to compare the efficacy, safety and tolerability of indisulam in combination with capecitabine (IC) versus capecitabine (C) monotherapy in patients with metastatic breast cancer who have previously been treated with an anthracycline and a taxane.

NCT ID: NCT00160563 Terminated - Asthma Clinical Trials

Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)

Start date: June 2004
Phase: Phase 3
Study type: Interventional

Prolongation of the EPAAC™ trial - NCT00152464 (The Early Prevention of Asthma in Atopic Children). 36 months study to evaluate the efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in young atopic children.

NCT ID: NCT00159640 Terminated - Pain Clinical Trials

Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia

Start date: February 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effectiveness of PD-217,014 in the treatment of chronic pain following a shingles infection.